跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,159 条关于
“AH-008”
全部
8,159
临床试验
2,898
药物
4,757
机构
14
资讯
490
2个月前
AH-008 Achieves Dual Regulatory Milestones with U.S. FDA IND Clearance and Taiwan CDE Index Case Designation for CIPN Prevention
10个月前
AnHorn Medicines' AI-Designed Hair Loss Drug AH-001 Completes Phase I Trial with Excellent Safety Profile
8个月前
FDA and EMA Grant Orphan Drug Designation to CPI-008 for Pancreatic Cancer Surgical Imaging
去年
AnHorn Medicines Initiates Phase I Trial of Novel Protein Degrader for Hair Loss
去年
DURECT's Larsucosterol Shows Promise in Alcohol-Associated Hepatitis Treatment
去年
KEYVIBE-008: Vibostolimab/Pembrolizumab Plus Chemotherapy Fails to Improve Survival in ES-SCLC
去年
Alcoholic Hepatitis Pipeline Insights 2024: Emerging Therapies and Market Prospects
2年前
Merck Discontinues Phase 3 KeyVibe-008 Trial of Vibostolimab and Pembrolizumab in Extensive-Stage Small Cell Lung Cancer
去年
Bausch Health Acquires DURECT for $63M to Advance Breakthrough Alcoholic Hepatitis Treatment
去年
Larsucosterol Shows Promising 90-Day Mortality Reduction in Phase 2b Alcohol-Associated Hepatitis Trial
第 1 页,共 49 页
上一页
下一页